Radioiodinated soluble canine fibrin. Preparation and evaluation as a thrombus localizing agent in the dog.
To develop a thrombus localizing tracer which has characteristics superior to labeled fibrinogen for external detection, we evaluated radioiodinated soluble fibrin. Labeled soluble fibrin was prepared by clotting and dissolving radioiodinated (131I) canine fibrinogen under specified conditions. Biological clearance studies revealed rapid clearance of the labeled soluble fibrin from the blood with a half-life of 5 hours. The accumulation of labeled soluble fibrin and fibrinogen in induced venous thrombi, coronary artery thrombi, and the myocardium was compared in dogs. In venous thrombi, soluble fibrin and fibrinogen exhibited maximum thrombus-blood ratios when they were injected 4 hours after thrombus induction; the thrombus-blood ratio was greater for soluble fibrin than it was for fibrinogen when these agents were injected 4, 8, or 24 hours after thrombosis induction. In induced coronary artery thrombi, soluble fibrin and fibrinogen accumulated to the same extent. Since the blood clearance of soluble fibrin is faster than that of fibrinogen, a higher thrombus-blood ratio was obtained with soluble fibrin in coronary artery thrombi. The thrombus-infarcted myocardium, thrombus-normal myocardium, and infarcted myocardium-normal myocardium ratios obtained with soluble fibrin were slightly higher than those obtained with fibrinogen. Thus, soluble fibrin offers some advantages when it is compared with fibrinogen as a thrombus detecting agent.
D000818:Animals; D003327:Coronary Disease / Q000175:diagnosis; D004195:Disease Models, Animal; D004285:Dogs; D005069:Evaluation Studies as Topic; D005337:Fibrin; D005340:Fibrinogen; D006207:Half-Life; D007457:Iodine Radioisotopes; D007553:Isotope Labeling; D012995:Solubility; D013924:Thrombophlebitis / Q000175:diagnosis; D013927:Thrombosis / Q000175:diagnosis*
D007457:Iodine Radioisotopes; D005337:Fibrin; D005340:Fibrinogen